Showing results (161-170 of 536) with videos related to
Sort By:
Pageof 54
BMC Pulmonary Medicine|January 13, 2010
A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthmaDave Singh, Binita Kane, Nestor A Molfino, et al.International Journal of Chronic Obstructive Pulmonary Disease|October 18, 2011
Safety of indacaterol in the treatment of patients with COPDJames F Donohue, Dave Singh, Oliver Kornmann, et al.International Journal of Chronic Obstructive Pulmonary Disease|May 3, 2018
Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cellsAndrew Higham, Pradeep Karur, Natalie Jackson, et al.Advances in Therapy|August 17, 2023
Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate-Severe SymptomsDave Singh, Sean Oosterholt, Ian Pavord, et al.International Immunopharmacology|December 4, 2014
The effects of corticosteroids on cytokine production from asthma lung lymphocytesManminder Kaur, Sophie Reynolds, Lucy J Smyth, et al.Immunotherapy|October 2, 2023
What role will ensifentrine play in the future treatment of chronic obstructive pulmonary disease patients? Implications from recent clinical trialsMario Cazzola, Clive Page, Luigino Calzetta, et al.British Journal of Clinical Pharmacology|September 23, 2014
Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary diseaseBrian R Leaker, Peter J Barnes, C Richard Jones, et al.BMC Pulmonary Medicine|October 30, 2014
The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthmaBrian R Leaker, Dave Singh, Ferhana Y Ali, et al.Cells|January 11, 2022
Dysregulation of the CD163-Haptoglobin Axis in the Airways of COPD PatientsAndrew Higham, James M Baker, Natalie Jackson, et al.American Journal of Respiratory and Critical Care Medicine|September 9, 2008
MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary diseaseSara Kirkham, Umme Kolsum, Karine Rousseau, et al.Pageof 54